A critical breakthrough in cancer study is emerging with the use of VHH fragments to reactivate dysfunctional p53. This vital cancer protector protein is frequently inactivated in several types of malignancies, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research